Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 1287 studies with search of: | United States, New Mexico |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
|
||||
2 | Recruiting |
Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
|
||||
3 | Recruiting |
Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
|
||||
4 | Recruiting |
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
|
||||
5 | Recruiting |
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
|
||||
6 | Active, not recruiting |
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
|
||||
7 | Active, not recruiting |
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
|
||||
8 | Recruiting |
Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
|
||||
9 | Active, not recruiting |
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
|
||||
10 | Active, not recruiting |
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
|
||||
11 | Recruiting |
Phase I/II Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
|
||||
12 | Active, not recruiting |
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
|
||||
13 | Completed |
Iressa Expanded Access Program (EAP)
|
||||
14 | Active, not recruiting |
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
|
||||
15 | Recruiting |
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
|
||||
16 | Active, not recruiting |
S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
|
||||
17 | Recruiting |
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
|
||||
18 | Recruiting |
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
|
||||
19 | Recruiting |
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
|
||||
20 | Active, not recruiting |
Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
|
Previous Page | Studies Shown (1-20) | Next (21-40) |